Novartis Partners with SHYFT

Jul 25, 2018
By Pharmaceutical Executive Editors

SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.

Novartis will use the following SHYFT solutions:

  • STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources
  • LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams

 

native1_300x100
lorem ipsum